Chalice Brands Stock Price, News & Analysis
Company Description
Chalice Brands (OTC Link: CHALF) is a publicly traded drug manufacturers - specialty & generic company in the Healthcare sector. The company has a market capitalization of $11.6M.
CHALF stock has gained 0.0% over the past year. Shares last traded at $0.0000.
This page provides a comprehensive overview of CHALF stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Chalice Brands (CHALF) stock last traded at $0.0000. At a market capitalization of $11.6M, CHALF is classified as a micro-cap stock with approximately 84.4M shares outstanding.
Latest News
Chalice Brands has 10 recent news articles. Of the recent coverage, 7 articles coincided with positive price movement and 2 with negative movement. Key topics include management, acquisition. View all CHALF news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Chalice Brands (CHALF) currently stands at 55 shares, representing 0.0% of the float. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Chalice Brands (CHALF) currently stands at 2.3 days, down 99.8% from the previous period. This days-to-cover ratio represents a balanced liquidity scenario for short positions. The days to cover has increased 129% over the past year, indicating improving liquidity conditions. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
CHALF Company Profile & Sector Positioning
Chalice Brands (CHALF) operates in the Drug Manufacturers - Specialty & Generic industry within the broader Healthcare sector and is listed on the OTC Link.
Investors comparing CHALF often look at related companies in the same sector, including Red Light Hollan (TRUFF), Argent BioPharma (RGTLF), Ayr Wellness Inc. (AYRWF), Elixxer (ELIXF), and Redwood Scientif (RSCI). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate CHALF's relative position within its industry.